Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Gastrointestinal 1

Conditions

Breast Neoplasms 42 Neoplasms 36 Fatigue 29 Depression 23 Prostatic Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, Follicular 15 Multiple Myeloma 14 Lung Neoplasms 14 Colorectal Neoplasms 14 Carcinoma, Non-Small-Cell Lung 14 Lymphoma, Non-Hodgkin 13 Lymphoma, Large B-Cell, Diffuse 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Pain 12 Lymphoma, Mantle-Cell 12 Lymphoma, B-Cell, Marginal Zone 12 Leukemia, Myeloid, Acute 12 Hodgkin Disease 12 Burkitt Lymphoma 12 Lymphoma, Large-Cell, Immunoblastic 11 Lymphoma, T-Cell, Cutaneous 10 Leukemia, Myeloid, Chronic-Phase 10 Leukemia, Hairy Cell 10 Blast Crisis 10 Anxiety Disorders 10 Neoplasm Metastasis 9 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9 Leukemia, Myeloid, Accelerated Phase 9 Carcinoma, Ovarian Epithelial 9

Interventions

Hyperthermic Intraperitoneal Chemotherapy 22 Paclitaxel 20 Cisplatin 20 Cytoreduction Surgical Procedures 16 Oxaliplatin 14 Carboplatin 13 Fluorouracil 10 Bevacizumab 9 Doxorubicin 7 Mitomycin 6 Leucovorin 6 Docetaxel 5 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4 Gemcitabine 4 Blood Specimen Collection 4 130-nm albumin-bound paclitaxel 4 sodium thiosulfate 3 catumaxomab 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 tremelimumab 2 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2 liposomal doxorubicin 2 Taxes 2 Palliative Care 2 Observation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02840331 2017-10-27

Hypericin-PDT

University Hospital Tuebingen

Phase 3 Unknown

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡